Xenvent-PD Syrup is a combination bronchodilator formulation containing Choline Theophyllinate (50mg/5ml) and Terbutaline (1.25mg/5ml), indicated for the management of bronchial asthma, chronic bronchitis, and other obstructive airway diseases. Choline Theophyllinate acts as a smooth muscle relaxant by inhibiting phosphodiesterase, leading to increased intracellular cyclic AMP levels, thereby facilitating bronchodilation and improving airflow. Terbutaline, a selective beta-2 adrenergic receptor agonist, complements this action by stimulating beta-2 receptors in bronchial smooth muscle, resulting in rapid bronchodilation and relief of bronchospasm. Xenvent-PD Syrup is particularly useful in pediatric and adult patients requiring effective airway relaxation and symptomatic relief from wheezing, breathlessness, and chest tightness. The syrup formulation allows for easy administration and dose adjustment according to patient response and severity of symptoms. It is essential to use Xenvent-PD under medical supervision, considering contraindications such as hypersensitivity to components, cardiac arrhythmias, and uncontrolled hypertension. Common adverse effects may include tachycardia, tremors, headache, and gastrointestinal disturbances. Caution is advised in patients with cardiovascular disorders, diabetes, and hyperthyroidism. Regular monitoring and adherence to prescribed dosage optimize therapeutic outcomes while minimizing potential side effects.